Research Analysts’ Weekly Ratings Updates for Option Care Health (OPCH)

Several analysts have recently updated their ratings and price targets for Option Care Health (NASDAQ: OPCH):

• 8/1/2026 – Option Care Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/30/2026 – Option Care Health had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $24.00 price target on the stock, down from $26.00.
• 7/30/2026 – Option Care Health was downgraded by Deutsche Bank Aktiengesellschaft from “buy” to “hold”. They now have a $24.00 price target on the stock, down from $26.00.
• 7/23/2026 – Option Care Health was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
• 7/17/2026 – Option Care Health had its “equal weight” rating reaffirmed by Stephens. They now have a $24.00 price target on the stock, down from $30.00.
• 7/17/2026 – Option Care Health was downgraded by Stephens from “overweight” to “equal weight”. They now have a $24.00 price target on the stock.
• 7/6/2026 – Option Care Health was upgraded by Zacks Research from “strong sell” to “hold”.
• 6/16/2026 – Option Care Health had its “buy” rating reaffirmed by UBS Group AG.
• 6/8/2026 – Option Care Health is now covered by The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $22.00 price target on the stock.
• 6/8/2026 – Option Care Health is now covered by The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $22.00 price target on the stock.

Insiders Place Their Bets

In related news, Director Timothy P. Sullivan bought 24,154 shares of the stock in a transaction dated Thursday, May 7th. The shares were acquired at an average cost of $20.69 per share, for a total transaction of $499,746.26. Following the acquisition, the director directly owned 73,383 shares in the company, valued at approximately $1,518,294.27. This trade represents a 49.06% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.70% of the stock is owned by company insiders.

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.